Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
With a focus on practical applications of biophysical techniques, this book links fundamental biophysics to the process of biopharmaceutical development. * Helps formulation and analytical scientists in pharma and biotech better understand and use biophysical methods * Chapters organized according to the sequential nature of the drug development process * Helps formulation, analytical, and bioanalytical scientists in pharma and biotech better understand and usestrengths and limitations of biophysical methods * Explains how to use biophysical methods, the information obtained, and what needs to…mehr
With a focus on practical applications of biophysical techniques, this book links fundamental biophysics to the process of biopharmaceutical development. * Helps formulation and analytical scientists in pharma and biotech better understand and use biophysical methods * Chapters organized according to the sequential nature of the drug development process * Helps formulation, analytical, and bioanalytical scientists in pharma and biotech better understand and usestrengths and limitations of biophysical methods * Explains how to use biophysical methods, the information obtained, and what needs to be presented in a regulatory filing, assess impact on quality and immunogenicity * With a focus on practical applications of biophysical techniques, this book links fundamental biophysics to the process of biopharmaceutical development.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
TAPAN K. DAS is the Director of the Mass Spectrometry and Biophysics Center of Excellence in the Analytical Development and Testing group at Bristol-Myers Squibb. He is responsible for biophysical and analytical development for biotherapeutics structure-function characterization, analytical comparability, protein particulate analysis, and support for commercial biotherapeutics products. Dr. Das is also the Chair of the Biotechnology Section of Ameri an Association of Pharmaceutical Scientists.
Inhaltsangabe
Preface vii About the Editor ix Contributors xi Section 1 Early Discovery Stages and Biotherapeutic Candidate Selection 1 Biophysical Methods Applied in Early Discovery of a Biotherapeutic: Case Study of an EGFR-IGF1R Bispecific Adnectin 3 Michael L. Doyle, James W. Bryson, Virginie Lafont, Zheng Lin, Paul E. Morin, Lumelle A. Schneeweis, Aaron P. Yamniuk, and Joseph Yanchunas Jr. 2 X-Ray Crystallography for Biotherapeutics 25 Glen Spraggon 3 Solubility and Early Assessment of Stability for Protein Therapeutics 65 Sheng-Jiun Wu, Gary L. Gilliland, and Yiqing Feng Section 2 First-in-Human and up to Proof-of-Concept Clinical Trials 4 Biophysical and Structural Characterization Needed Prior to Proof of Concept 95 Angela W. Blake-Haskins, Yen-Huei Lin, Zhuchun Wu, Melissa D. Perkins, and Thomas M. Spitznagel 5 Nucleation, Aggregation, and Conformational Distortion 125 Christopher J. Roberts 6 Utilization of Chemical Labeling and Mass Spectrometry for the Biophysical Characterization of Biopharmaceuticals 151 Justin B. Sperry and Lisa M. Jones 7 Application of Biophysical and High-Throughput Methods in the Preformulation of Therapeutic Proteins-Facts and Fictions 173 Ahmad M. Abdul-Fattah and Hanns-Christian Mahler 8 Bioanalytical Methods and Immunogenicity Assays 207 Bonita Rup, Corinna Krinos-Fiorotti, Boris Gorovits, and Hendrik Neubert 9 Structures and Dynamics of Proteins Probed by UV Resonance Raman Spectroscopy 243 Brian S. Leigh, Diana E. Schlamadinger, and Judy E. Kim 10 Freezing- and Drying-Induced Micro- and Nano-Heterogeneity in Biological Solutions 269 Alptekin Aksan, Vishard Ragoonanan, and Carol Hirschmugl Section 3 Phase III and Commercial Development 11 Late-Stage Product Characterization: Applications in Formulation, Process, and Manufacturing Development 287 Christine P. Chan and Li Shi 12 Biophysical Analyses Suitable for Chemistry, Manufacturing, and Control Sections of the Biologic License Application (BLA) 317 Zahra Shahrokh, Nazila Salamat-Miller, and John J. Thomas Index 355
Preface vii About the Editor ix Contributors xi Section 1 Early Discovery Stages and Biotherapeutic Candidate Selection 1 Biophysical Methods Applied in Early Discovery of a Biotherapeutic: Case Study of an EGFR-IGF1R Bispecific Adnectin 3 Michael L. Doyle, James W. Bryson, Virginie Lafont, Zheng Lin, Paul E. Morin, Lumelle A. Schneeweis, Aaron P. Yamniuk, and Joseph Yanchunas Jr. 2 X-Ray Crystallography for Biotherapeutics 25 Glen Spraggon 3 Solubility and Early Assessment of Stability for Protein Therapeutics 65 Sheng-Jiun Wu, Gary L. Gilliland, and Yiqing Feng Section 2 First-in-Human and up to Proof-of-Concept Clinical Trials 4 Biophysical and Structural Characterization Needed Prior to Proof of Concept 95 Angela W. Blake-Haskins, Yen-Huei Lin, Zhuchun Wu, Melissa D. Perkins, and Thomas M. Spitznagel 5 Nucleation, Aggregation, and Conformational Distortion 125 Christopher J. Roberts 6 Utilization of Chemical Labeling and Mass Spectrometry for the Biophysical Characterization of Biopharmaceuticals 151 Justin B. Sperry and Lisa M. Jones 7 Application of Biophysical and High-Throughput Methods in the Preformulation of Therapeutic Proteins-Facts and Fictions 173 Ahmad M. Abdul-Fattah and Hanns-Christian Mahler 8 Bioanalytical Methods and Immunogenicity Assays 207 Bonita Rup, Corinna Krinos-Fiorotti, Boris Gorovits, and Hendrik Neubert 9 Structures and Dynamics of Proteins Probed by UV Resonance Raman Spectroscopy 243 Brian S. Leigh, Diana E. Schlamadinger, and Judy E. Kim 10 Freezing- and Drying-Induced Micro- and Nano-Heterogeneity in Biological Solutions 269 Alptekin Aksan, Vishard Ragoonanan, and Carol Hirschmugl Section 3 Phase III and Commercial Development 11 Late-Stage Product Characterization: Applications in Formulation, Process, and Manufacturing Development 287 Christine P. Chan and Li Shi 12 Biophysical Analyses Suitable for Chemistry, Manufacturing, and Control Sections of the Biologic License Application (BLA) 317 Zahra Shahrokh, Nazila Salamat-Miller, and John J. Thomas Index 355
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
